List view / Grid view
8 June 2015 | By Victoria White
Sanofi has announced results from two extension studies where participants with diabetes received Toujeo or Lantus treatment for a total of 12 months...
8 June 2015 | By Victoria White
Phase 3b findings show adults with T2D treated with Xultophy demonstrate statistically significant reduction in HbA1c and a lower rate of hypoglycaemia...
8 June 2015 | By Victoria White
Eli Lilly and Company has committed another 780,000 vials of insulin to the International Diabetes Federation's Life for a Child programme...
2 June 2015 | By Victoria White
NICE has recommended aflibercept solution for injection and dexamethasone intravitreal implant as possible treatment options for diabetic macular oedema...
28 May 2015 | By Victoria White
Synjardy has been granted marketing authorisation by the European Commission for the treatment of adults with type 2 diabetes (T2D) in the European Union...
27 May 2015 | By Victoria White
The SCALE Obesity and Prediabetes trial met its primary endpoint, demonstrating that ongoing treatment with Saxenda delayed the onset of type 2 diabetes...
29 April 2015 | By Victoria White
The EC has granted marketing authorisation in Europe for Sanofi’s Toujeo for the treatment of type 1 and type 2 diabetes mellitus in adults...
16 April 2015 | By Victoria White
Targacept has announced TC-6499 did not meet the primary endpoint of a Phase 1/2 exploratory study as a treatment for diabetic gastroparesis...
14 April 2015 | By Victoria White
Merck is introducing diabetes management training for more than 5,000 Maharashtra University students as part of the Merck Capacity Advancement Program...
14 April 2015 | By Victoria White
The Changing Diabetes in Children programme, a scheme that has provided free insulin to 13,000 children since 2009, has been extended by three years.
13 April 2015 | By Victoria White
Novo Nordisk has opened a manufacturing facility in the Kaluga region of Russia for formulation and filling of modern insulin for the treatment of diabetes...
30 March 2015 | By Victoria White
BioDelivery Sciences announced that Clonidine Topical Gel did not meet statistical significance compared to placebo in the Phase 3 clinical study...
30 March 2015 | By Victoria White
New data show that the intravitreal injection regimens associated with treating retinal disease can have a detrimental effect on patient quality of life....
30 March 2015 | By Victoria White
BI and Lilly announce they have received a positive opinion from CHMP, recommending empagliflozin/metformin hydrochloride for the treatment type 2 diabetes...
27 March 2015 | By Victoria White
Novo Nordisk has announced that it has decided to resubmit New Drug Applications of Tresiba and Ryzodeg to the FDA within the month.
